Investor
Ascenta Capital
A biotech venture capital firm supporting companies in translating preclinical science into clinical medicines through concentrated investments.
Stage
Not confirmed
Sectors
Digital Health
Cheque
$15m–$30m
Invests in
Global
Sectors
Digital Health
About
The firm assists companies as they grow from scientific foundations to advance the clinical development of medicines. It makes concentrated investments and works in collaboration to support management teams with strategic and operational experience. The strategy focuses on partnering with companies that have development candidates to translate preclinical science into early human data. It also invests in multi-medicine platforms where growth and strategy offer potential upside.